Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis

Journal of the Neurological Sciences

Volumn 300, Issue 1-2, 2011, Pages 59-62

  Minami, Naoya ^a   Fujiki, Naoto ^a   Doi, Shizuki ^a   Shima, Koji ^b   Niino, Masaaki ^a,d   Kikuchi, Seiji ^a   Sasaki, Hidenao ^c  

^a HOKKAIDO MEDICAL CENTER   (Japan)

^b Sapporo Neurology Clinic   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Department of Clinical Research ^*  (Japan)

Author keywords

Immunosuppressant; Myasthenia gravis; Side effect; Steroid; Tacrolimus; Therapy

Indexed keywords

PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BONE DISEASE; CANDIDIASIS; CATARACT; CHRONIC GASTRITIS; CLINICAL ARTICLE; DEPRESSION; DERMATOMYCOSIS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRY EYE; FEMALE; FOLLOW UP; FRACTURE; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERTENSION; INFECTION; LOW DRUG DOSE; MALE; MYASTHENIA GRAVIS; NEPHROLITHIASIS; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERUS MYOMA; VERTEBRAL CANAL STENOSIS;

ACTIVITIES OF DAILY LIVING; ADULT; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISOLONE; RECEPTORS, CHOLINERGIC; TACROLIMUS;

EID: 78650515512     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.09.033     Document Type: Article

References (17)

1. M.N. Meriggioli, and D.B. Sanders Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity Lancet Neurol 8 2009 475 490
2. D.B. Drachman Myasthenia gravis N Engl J Med 330 1994 1797 1810 (Pubitemid 2089285)
3. T. Kino, H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, and M. Okuhara FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics J Antibiot (Tokyo) 40 1987 1249 1255 (Pubitemid 17138109)
4. J.M. Ponseti, J. Azem, J.M. Fort, A. Codina, J.B. Montoro, and M. Armengol Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study Clin Neurol Neurosurg 107 2005 187 190 (Pubitemid 40502223)
5. J.M. Ponseti, J. Azem, J.M. Fort, M. López-Cano, R. Vilallonga, and M. Buera Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis Neurology 64 2005 1641 1643 (Pubitemid 40617711)
6. J.M. Ponseti, J. Gamez, J. Azem, M. López-Cano, R. Vilallonga, and M. Armengol Tacrolimus for myasthenia gravis: a clinical study of 212 patients Ann NY Acad Sci 1132 2008 254 263 (Pubitemid 351841343)
7. J.M. Ponseti, J. Gamez, J. Azem, J.M. Fort, M. López-Cano, and R. Vilallonga Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study Curr Med Res Opin 23 2007 1269 1278 (Pubitemid 46998436)
8. T. Konishi, Y. Yoshiyama, M. Takamori, K. Yagi, and E. Mukai Japanese FK506 MG Study Group. Clinical study of FK506 in patients with myasthenia gravis Muscle Nerve 28 2003 570 574
9. N. Wakata, T. Saito, S. Tanaka, T. Hirano, and K. Oka Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis Clin Neurol Neurosurg 106 2003 5 8 (Pubitemid 37468493)
10. G.I. Wolfe, L. Herbelin, S.P. Nations, B. Foster, W.W. Bryan, and R.J. Barohn Myasthenia gravis activities of daily living profile Neurology 52 1999 1487 1489 (Pubitemid 29190546)
11. H. Yoshikawa, K. Mabuchi, Y. Yasukawa, M. Takamori, and M. Yamada Low-dose tacrolimus for intractable myasthenia gravis J Clin Neurosci 9 2002 627 628 (Pubitemid 35364731)
12. T. Konishi, Y. Yoshiyama, M. Takamori, and T. Saida Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus) J Neurol Neurosurg Psychiatry 76 2005 448 450 (Pubitemid 40299146)
13. Y. Nagane, K. Utsugisawa, D. Obara, R. Kondoh, and Y. Terayama Efficacy of low-dose FK506 in the treatment of Myasthenia gravis - a randomized pilot study Eur Neurol 53 2005 146 150 (Pubitemid 40864306)
14. Y. Shimojima, M. Matsuda, T. Gono, W. Ishii, T. Tokuda, and S. Ikeda Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone J Clin Neurosci 13 2006 39 44 (Pubitemid 43061126)
15. M. Alessiani, U. Cillo, J.J. Fung, W. Irish, K. Abu-Elmagd, and A. Jain Adverse effects of FK 506 overdosage after liver transplantation Transplant Proc 25 1993 628 634 (Pubitemid 23082500)
16. M. Tada, T. Shimohata, M. Tada, M. Oyake, S. Igarashi, and O. Onodera Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis J Neurol Sci 247 2006 17 20 (Pubitemid 44107375)
17. Y. Furukawa, H. Yoshikawa, K. Iwasa, and M. Yamada Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis J Neuroimmunol 195 2008 108 115